Tumor-reactive antibodies evolve from non-binding and autoreactive precursors.
Cell. 2022 Mar 31;185(7):1208-1222.e21. doi: 10.1016/j.cell.2022.02.012. Epub 2022 Mar 18.
Cell. 2022.
PMID: 35305314